CD8A and disease arising from reactivation of latent virus: By strengthening the CD8+ T cell response, which can be bypassed by HSV-1 as the virus reactivates and causes recurrent disease, NTP will facilitate a more robust host immune response that will exert greater immune control in limiting acute infection and suppressing the reactivation of latent infection.